LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Exploring structural determinants of neuroprotection bias on novel glypromate conjugates with bioactive amines.

    Silva-Reis, Sara C / Costa, Vera M / Correia da Silva, Daniela / Pereira, David M / Correia, Xavier Cruz / Costa-Almeida, Hugo F / García-Mera, Xerardo / Rodríguez-Borges, José E / Sampaio-Dias, Ivo E

    European journal of medicinal chemistry

    2024  Band 267, Seite(n) 116174

    Abstract: Neurodegenerative disorders of the central nervous system (CNS) such as Alzheimer's and Parkinson's diseases, afflict millions globally, posing a significant public health challenge. Despite extensive research, a critical hurdle in effectively treating ... ...

    Abstract Neurodegenerative disorders of the central nervous system (CNS) such as Alzheimer's and Parkinson's diseases, afflict millions globally, posing a significant public health challenge. Despite extensive research, a critical hurdle in effectively treating neurodegenerative diseases is the lack of neuroprotective drugs that can halt or reverse the underlying disease processes. In this work, we took advantage of the neuroprotective properties of the neuropeptide glycyl-l-prolyl-l-glutamic acid (Glypromate) for the development of new peptidomimetics using l-pipecolic acid as a proline surrogate and exploring their chemical conjugation with relevant active pharmaceutical ingredients (API) via a peptide bond. Together with prolyl-based Glypromate conjugates, a total of 36 conjugates were toxicologically and biologically evaluated. In this series, the results obtained showed that a constrained ring (l-proline) at the central position of the peptide motif accounts for enhanced toxicological profiles and biological effects using undifferentiated and differentiated human neuroblastoma SH-SY5Y cells. Additionally, it was shown that biased biological responses are API-dependent. Conjugation with (R)-1-aminoindane led to a 38-43% reduction of protein aggregation induced by Aβ
    Mesh-Begriff(e) Humans ; Neuroprotection ; Cell Line, Tumor ; Neuroblastoma/drug therapy ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Oxidopamine/toxicity ; Oligopeptides/pharmacology ; Oligopeptides/therapeutic use ; Neurodegenerative Diseases ; Neuropeptides/pharmacology ; Apoptosis
    Chemische Substanzen glycyl-prolyl-glutamic acid (ZYK4RVV5LS) ; Neuroprotective Agents ; Oxidopamine (8HW4YBZ748) ; Oligopeptides ; Neuropeptides
    Sprache Englisch
    Erscheinungsdatum 2024-01-26
    Erscheinungsland France
    Dokumenttyp Journal Article
    ZDB-ID 188597-2
    ISSN 1768-3254 ; 0009-4374 ; 0223-5234
    ISSN (online) 1768-3254
    ISSN 0009-4374 ; 0223-5234
    DOI 10.1016/j.ejmech.2024.116174
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.B 784: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences.

    Silva-Reis, Sara C / Sampaio-Dias, Ivo E / Costa, Vera M / Correia, Xavier Cruz / Costa-Almeida, Hugo F / García-Mera, Xerardo / Rodríguez-Borges, José E

    ACS chemical neuroscience

    2023  Band 14, Heft 4, Seite(n) 554–572

    Abstract: Neurodegenerative diseases of the central nervous system (CNS) pose a serious health concern worldwide, with a particular incidence in developed countries as a result of life expectancy increase and the absence of restorative treatments. Presently, ... ...

    Abstract Neurodegenerative diseases of the central nervous system (CNS) pose a serious health concern worldwide, with a particular incidence in developed countries as a result of life expectancy increase and the absence of restorative treatments. Presently, treatments for these neurological conditions are focused on managing the symptoms and/or slowing down their progression. As so, the research on novel neuroprotective drugs is of high interest. Glypromate (glycyl-l-prolyl-l-glutamic acid, also known as GPE), an endogenous small peptide widespread in the brain, holds great promise to tackle neurodegenerative diseases such as Parkinson's, Alzheimer's, and Huntington's, s well as other CNS-related disorders like Rett and Down's syndromes. However, the limited pharmacokinetic properties of Glypromate hinder its clinical application. As such, intense research has been devoted to leveraging the pharmacokinetic profile of this neuropeptide. This review aims to offer an updated perspective on Glypromate research by exploring the vast array of chemical derivatizations of more than 100 analogs described in the literature over the past two decades. The collection and discussion of the most relevant structure-activity relationships will hopefully guide the discovery of new Glypromate-based neuroprotective drugs.
    Mesh-Begriff(e) Humans ; Neuroprotective Agents/therapeutic use ; Neuroprotective Agents/pharmacokinetics ; Neuropeptides ; Neurodegenerative Diseases/drug therapy ; Central Nervous System Diseases ; Neurosciences
    Chemische Substanzen glycyl-prolyl-glutamic acid (ZYK4RVV5LS) ; Neuroprotective Agents ; Neuropeptides
    Sprache Englisch
    Erscheinungsdatum 2023-02-03
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.2c00675
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  3. Artikel: A Convenient On-Site Oxidation Strategy for the N-Hydroxylation of Melanostatin Neuropeptide Using Cope Elimination

    Sampaio-Dias, Ivo E. / Silva-Reis, Sara C. / Pires-Lima, Beatriz L. / Correia, Xavier Cruz / Costa-Almeida, Hugo F.

    Synthesis

    2021  Band 54, Heft 08, Seite(n) 2031–2036

    Abstract: A convenient synthetic protocol for the unprecedented N -hydroxylation of proline residue in Melanostatin (MIF-1) neuropeptide is reported. This methodology is grounded on the incorporation of N -(cyanoethyl)prolyl residue followed by on-site oxidation ...

    Abstract A convenient synthetic protocol for the unprecedented N -hydroxylation of proline residue in Melanostatin (MIF-1) neuropeptide is reported. This methodology is grounded on the incorporation of N -(cyanoethyl)prolyl residue followed by on-site oxidation by Cope elimination with m -chloroperbenzoic acid, exploring the unrecognized dual role of the cyanoethyl group as an effective N -protecting group under peptide synthesis conditions and as a suitable leaving group during the chemoselective on-site N -oxidation. Following this protocol N -hydroxy-MIF-1 is obtained in 78% global yield from N -(cyanoethyl)- l -proline. This synthetic approach opens a new avenue for access to N -hydroxylated Melanostatin analogues with direct application in neurochemistry and Parkinson’s research.
    Schlagwörter Cope elimination ; Melanostatin ; Michael addition ; MIF-1 ; secondary hydroxylamines
    Sprache Englisch
    Erscheinungsdatum 2021-11-11
    Verlag Georg Thieme Verlag KG
    Erscheinungsort Stuttgart ; New York
    Dokumenttyp Artikel
    ZDB-ID 2033062-5
    ISSN 1437-210X ; 0039-7881
    ISSN (online) 1437-210X
    ISSN 0039-7881
    DOI 10.1055/a-1695-1095
    Datenquelle Thieme Verlag

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang